Drew N. Kelner, Ph.D.
Drew Nathaniel Kelner, Ph.D., is a biochemist and immunologist with 39 years of experience in the biopharmaceutical industry, including twelve years at Amgen, the world’s largest independent biotechnology company. During his career, he has been engaged in the development of innovative med...
Taming Cancer: 21st Century Biology and the Future of Cancer Medicine
Taming Cancer offers a hopeful and compelling vision of a future when metastatic cancer will no longer be a harbinger of suffering and death. Rather, cancer will be managed as a chronic ailment over long time frames, like diabetes and rheumatoid arthritis. For the most fortunate patients, the elimination of cancer cells from the body—the long-sought cure for metastatic cancer—will become a reality for increasing numbers of patients.This powerful vision is enabled by the ongoing emergence of a new paradigm in cancer medicine that began at the dawn of this new century. The long-established, ...